Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

DMACDMAC
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in DIAMEDICA THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 168,066 shares of DMAC (DIAMEDICA THERAPEUTICS INC), worth $1.2M as of 2026-Q2. The position was increased (+183.5% shares). DMAC represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$1.2M

Current Shares

168,066

Total Value Change

+$808,797

Total Shares Change

+99,118

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
168,066
+183.5%
$1.2M0.0%$7.04
41
2026-Q1
Decreased
59,288
-54.2%
$401,3800.0%$6.77
0
2025-Q4
Increased
129,388
+67.4%
$1M0.0%$7.96
37
2025-Q3
Increased
77,292
+331.7%
$530,9960.0%$6.87
39
2025-Q2
Decreased
17,904
-85.3%
$69,8260.0%$3.90
0
2025-Q1
Increased
121,802
+76.7%
$461,6300.0%$3.79
36
2024-Q4
New
68,948
-
$374,3880.0%$5.43
33

Other major holders of DMAC: COOPERMAN LEON G, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used